Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

- PMLiVE

Tradjenta diabetes uses expanded in US

Lilly-Boehringer diabetes drug available as add-on to insulin therapy

- PMLiVE

Takeda set for US sales slump as generic Actos arrives

Mylan, Ranbaxy and Teva to launch cut-price versions of diabetes drug

Novartis reaffirms commitment to UK respiratory research site

Will slim down and redevelop Horsham facility

- PMLiVE

Sanofi launches insulin Q&A YouTube channel

Diabetes social media initiative will see pharma company answer patient queries

- PMLiVE

Antibody-drug conjugates on the up in cancer

Mylotarg served as a lesson of the pitfalls of ADCs: two years after it was pulled from the market some of the ADCs now in development will emerge as blockbusters

- PMLiVE

Reynolds-MacKenzie makes senior appointments

Nita Ares and Jennifer Garratt join, while Monica Small is promoted

- PMLiVE

Empowering the intranet

Assessing your intranet portal and whether it’s actually working

- PMLiVE

Reynolds-MacKenzie bolsters its leadership team

Nita Ares and Jennifer Garratt join, while Monica Small is promoted

- PMLiVE

Pharma’s iPad love affair continues

Number of US doctors who have seen a sales rep with an iPad doubles

- PMLiVE

Watson sues FDA over generic Actos ruling

Follows regulator's decision not to grant shared exclusivity for a version of Takeda and Lilly's big-selling diabetes drug

- PMLiVE

Roche’s Perjeta gets green light in Switzerland

Personalised cancer drug wins first European approval

- PMLiVE

CROS NT appoints Andrew MacGarvey to lead new UK office

Contract research organisation's new facility will be based in Milton Keynes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links